Results 31 to 40 of about 111,089 (390)
Relationship between device acceptance and patient-reported outcomes in left ventricular assist device (LVAD) recipients [PDF]
The number of Left Ventricular Assist Devices (LVADs) implanted each year is rising. Nevertheless, there are minimal data on device acceptance after LVAD implant, and on its relationship with patient-reported outcomes. We designed a cross-sectional study
Adamo, Luigi+7 more
core +2 more sources
OBJECTIVES Right heart failure after left ventricular assist device (LVAD) implantation is associated with significant morbidity and mortality. A new generation of percutaneous right ventricular assist devices (RVADs) may mitigate the need for invasive ...
M. Salna+11 more
semanticscholar +1 more source
Left Ventricular Assist Devices and the Kidney [PDF]
Left ventricular assist devices (LVADs) are common and implantation carries risk of AKI. LVADs are used as a bridge to heart transplantation or as destination therapy. Patients with refractory heart failure that develop chronic cardiorenal syndrome and CKD often improve after LVAD placement. Nevertheless, reversibility of CKD is hard to predict.
Gerin R. Stevens+7 more
openaire +2 more sources
Implantable left ventricular assist device (LVAD) is a state-of-the-art treatment for adults and children with end-stage heart failure. The early and late period after LVAD implantation can be severely complicated.
V. N. Poptsov+4 more
doaj +1 more source
Initial experience with the left ventricular assist device TransCoreTM [PDF]
Cardiogenic shock is a condition associated to high mortality rates. For decades, the treatment consisted of vasoactive drugs and intra-aortic balloon pump.
Alves, Claudia Maria Rodrigues+3 more
core +1 more source
Outcomes of patients after successful left ventricular assist device explantation: a EUROMACS study
Sufficient myocardial recovery with the subsequent explantation of a left ventricular assist device (LVAD) occurs in approximately 1–2% of the cases. However, follow‐up data about this condition are scarcely available in the literature.
C. Antonides+12 more
semanticscholar +1 more source
Editorial: Management of right ventricular failure: pathophysiology, medical treatment and use of ventricular assist devices [PDF]
Left ventricular assist device; Advanced heart failure; Right ventricular failureDispositiu d'assistència ventricular esquerre; Insuficiència cardíaca avançada; Insuficiència del ventricle dretDispositivo de asistencia ventricular izquierda ...
Barrabés, José A.+3 more
core +1 more source
Left ventricular assist device.
To the Editor: The value of angiotensin-converting– enzyme (ACE) inhibitors, beta-blockers, and spironolactone has been well established by the results of numerous clinical trials. About 70 percent of the patients described by Rose et al. were treated with ACE inhibitors or angiotensin II–receptor antagonists; 35 to 40 percent received spironolactone ...
Jiménez-Navarro, Manuel+2 more
openaire +4 more sources
Background The use of a Left Ventricular Assist Device (LVAD) in patients with advanced heart failure refractory to optimal medical management has progressed steadily over the past two decades. Data have demonstrated reduced LVAD efficacy, worse clinical
David T. Huang+33 more
doaj +1 more source
Extended right posterior liver sectionectomy for HCC in a patient with left ventricular assist device—a case report [PDF]
Successful implementation of left ventricular assist devices lead to a prolonged survival in patients with chronic terminal heart failure. Thus, patients with pre-existing left ventricular assist devices with abdominal comorbidities requiring abdominal ...
Lojewski, Christian+6 more
core +1 more source